Cereulide-Tainted Infant Formula Recalled in US After New Zealand Regulatory Warning

Key facts

• a2 Milk Company voluntarily recalls 63,078 tins of a2 Platinum Premium infant formula (0-12 months, USA label).
• Recall affects three batch numbers: 2210269454, 2210324609, 2210321712, with use-by dates July 15, 2026, Jan 15, 2027, and Jan 21, 2027.
• Approximately 16,428 tins were sold to consumers via Amazon, Meijer, and a2MC's website.
• as of May 4, 2026.
• Cereulide, a heat-stable toxin from Bacillus cereus, detected during additional testing following New Zealand MPI guidance on April 15, 2026.
• Formula was imported under Operation Fly Formula, which expired Dec 31, 2025; product discontinued before recall.
• Cereulide contamination linked to arachidonic acid (ARA) oil used in production; source not specified by a2MC.
• at least 144 suspected/confirmed cereulide cases across 10 countries from Dec 2016 to Feb 2026.

Recall Triggered by Toxin Detection in Imported Formula

The New Zealand-based a2 Milk Company has initiated a voluntary recall of 63,078 tins of its a2 Platinum Premium Infant Formula for infants 0-12 months, sold under the USA label. The action follows the detection of cereulide, a potent bacterial toxin, during additional testing prompted by updated guidance from New Zealand's Ministry for Primary Industries on April 15, 2026. The recall covers three specific batch numbers: 2210269454, 2210324609, and 2210321712, with use-by dates of July 15, 2026, January 15, 2027, and January 21, 2027, respectively. Of the total tins implicated, an estimated 16,428 have been sold to consumers through the company's website, Amazon, and Meijer stores. The product had already been discontinued and removed from sale prior to the recall, as the company's importation rights under Operation Fly Formula expired on December 31, 2025.

No Illnesses Reported but Risks Are Severe for Infants

The U.S. Food and Drug Administration has stated that no confirmed incidents of illness or harm have been reported in connection with the recalled formula. However, cereulide, produced by certain strains of Bacillus cereus, poses serious health risks, particularly to infants. The toxin is heat-stable, meaning boiling water cannot neutralize it. Symptoms of cereulide poisoning typically appear within 30 minutes to six hours after ingestion and include nausea, vomiting, abdominal pain, and in severe cases, dehydration and electrolyte imbalance. The World Health Organization warns that these effects can be especially dangerous for infants. The company has issued guidance to U.S. consumers on steps to take if they have purchased the affected product.

Contamination Linked to ARA Oil, Source Unclear

The a2 Milk Company has not specified the exact source of the cereulide contamination, stating only that it may be related to an ingredient in the product. Industry-wide investigations have identified contaminated arachidonic acid (ARA) oil as a likely vector. ARA oil is commonly used in infant formula production, and several multinational companies—including Nestle, Danone, and Lactalis—pulled products off shelves earlier in January due to similar concerns. The company emphasized that the recall is limited to the USA label product, which has a different formulation and relevant ingredient compared to the English label a2 Platinum formula sold in Australia, New Zealand, South Korea, Vietnam, and through cross-border channels into China. Products in those markets are not affected.

Operation Fly Formula and Regulatory Timeline

The recalled formula was imported into the United States under Operation Fly Formula, a 2022 federal initiative that used government planes and personnel to expedite shipments of infant formula during a nationwide shortage. The a2 Milk Company's participation in the program ended on December 31, 2025, and the product was discontinued before the recall was initiated. The recall was set in motion after the New Zealand Ministry for Primary Industries released an industry update on April 15, 2026, outlining new expectations for managing cereulide. Additional testing conducted in accordance with that guidance detected the toxin in the affected batches. The company is coordinating with the FDA on the recall and has communicated directly with U.S. consumers.

Global Cereulide Concerns and WHO Data

Cereulide contamination in infant formula has become a growing international concern. According to the World Health Organization, from December 2016 to February 2026, at least 99 countries and territories received infant formula products subject to recalls due to cereulide. at least 144 suspected and confirmed cases across 10 countries, though the full root cause analysis and traceability of all affected batches remain under investigation. The toxin is produced by certain strains of Bacillus cereus and can cause severe vomiting, diarrhea, or unusual lethargy. The WHO's March 13 press release highlighted the ongoing nature of the investigation, noting that the complete scope of contamination is still being determined.

Separate Study Highlights Antibiotic Resistance in Newborn Infections

In a related but distinct development, researchers from the University of Missouri-Kansas City School of Medicine and Children's Mercy Hospital Kansas City published a study in Open Forum Infectious Diseases examining antibiotic resistance in Escherichia coli infections among newborns. Analyzing blood culture isolates from 2006 to 2021, they found rising rates of resistance to recommended antibiotics. Of 54 newborns with E. coli bacteremia, seven developed early-onset sepsis, 12 were treated for meningitis, and two had necrotizing enterocolitis. Five infants died, including three born preterm. The mortality rate was 19% in preterm newborns versus 5% in term newborns. The researchers emphasized that understanding resistance patterns is crucial for developing effective prevention and treatment strategies.

The bottom line

• The a2 Milk Company voluntarily recalled 63,078 tins of a2 Platinum Premium infant formula (USA label) after cereulide detection; 16,428 tins were sold.
• No illnesses have been confirmed, but cereulide can cause severe vomiting, dehydration, and electrolyte imbalance in infants.
• The contamination likely stems from ARA oil, a common ingredient; the source remains unconfirmed by the company.
• The recall is limited to the U.S. market; products sold in Australia, New Zealand, and other countries are unaffected.
• at least 144 cereulide cases globally from 2016 to 2026, with investigations ongoing.
• A separate study found rising antibiotic resistance in E. coli from newborn infections, with higher mortality in preterm infants.